Publicly Available Datasets

Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, a CIBMTR study.

Start Year of Infusion:2002

First Author:Naik Seema

Composite GRFS and CRFS outcomes after adult alternative donor HCT.

Start Year of Infusion:2003

First Author:Rohtesh Mehta

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

Start Year of Infusion:1995

First Author:Aleksandr Lazaryan

Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: A time-trend analysis.

Start Year of Infusion:2000

First Author:Shah NN

Comparison of high doses of total body irradiation in myeloablative conditioning before hematopoietic cell transplantation.

Start Year of Infusion:2001

First Author:Mitchell Sabloff

Maintenance tyrosine kinase inhibitors following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia: A Center for International Blood and Marrow Transplant Research Study.

Start Year of Infusion:2007

First Author:Zachariah DeFilipp

Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases.

Start Year of Infusion:1995

First Author:Justine Kahn

Donor HLA-E status associates with disease-free survival and transplant-related mortality after non In vivo T cell-depleted HSCT for acute leukemia.

Start Year of Infusion:2000

First Author:Chrysanthi Tsamadou

Weighty choices: Selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

Start Year of Infusion:2006

First Author:Nosha Farhadfar

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

Start Year of Infusion:2002

First Author:David Buchbinder

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.

Start Year of Infusion:2006

First Author:Celalettin Ustun

Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.

Start Year of Infusion:1985

First Author:Megan Herr

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

Start Year of Infusion:2008

First Author:Scott Solomon

Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy.

Start Year of Infusion:2008

First Author:Narendranath Epperla

Choice of conditioning regimens for BMT in SAA

Start Year of Infusion:2000

First Author:Nelli Bejanyan

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: A retrospective multicentre, cohort study.

Start Year of Infusion:2008

First Author:Mary Eapen

Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.

Start Year of Infusion:2003

First Author:Deepa Jagadeesh

The role of donor lymphocyte infusion (DLI) in post hematopoietic cell transplant (HCT) relapse for chronic myeloid leukemia (CML) in the tyrosine kinase inhibitor (TKI) era.

Start Year of Infusion:2002

First Author:Sarah Schmidt

Collection of peripheral blood progenitor cells in 1 day is associated with decreased donor toxicity compared to 2 days in unrelated donors.

Start Year of Infusion:2006

First Author:Jack Hsu